Wall Street Access Asset Management »

Corvus Pharmaceuticals shares owned by Wall Street Access Asset Management

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Wall Street Access Asset Management from 13F filings

Historical chart of Wall Street Access Asset Management investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Wall Street Access Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Wall Street Access Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $552 75 7.37

More positions owned by Wall Street Access Asset Management

iShares S&P 500 Index (IVV)
Berkshire Hathaway Inc Del Cl A Common Stock (BRK.A)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class C cs (GOOG)
Invesco S&p 500 Equal Weight Etf (RSP)
Amazon (AMZN)
Berkshire Hathaway (BRK.B)
Facebook Inc cl a (META)
American Balanced Fund Class F2 Mutual Fund (AMBFX)
T. Rowe Price Capital Appreciation Fund Class I Mutual Fund (TRAIX)
American Growth Fund Of America Class F2 Mutual Fund (GFFFX)
Dimensional Etf Trust (DFAS)
American Capital Income Builder Fund Class F2 Mutual Fund (CAIFX)
Vanguard Index Fds Vanguard Value Etf Common Stock (VTV)

View all positions for Wall Street Access Asset Management

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
Point72 Asset Management
BlackRock
Vanguard Group
Adams Street Partners
Rtw Investments
Vivo Capital
Foresite Capital Management VI
Geode Capital Management
Perceptive Advisors
State Street Corporation
Morgan Stanley
Northern Trust
Goldman Sachs Group
Sphera Funds Management

View all funds holding Corvus Pharmaceuticals